Selected article for: "current situation and general population"

Author: Liotti, Lucia; Bianchi, Annamaria; Bottau, Paolo; Caimmi, Silvia; Crisafulli, Giuseppe; Franceschini, Fabrizio; Mori, Francesca; Paglialunga, Claudia; Saretta, Francesca; Caffarelli, Carlo
Title: COVID-19 Vaccines in Children with Cow’s Milk and Food Allergies
  • Cord-id: tglbwhbp
  • Document date: 2021_7_30
  • ID: tglbwhbp
    Snippet: The COVID-19 pandemic is the most challenging global health crisis of our times. Vaccination against COVID-19 plays a key role to control the current pandemic situation. The risk of allergic reactions to new COVID-19 vaccines is low. However, there is a debate on the safety in allergic patients following post marketing findings by different agencies. Our aim is to understand from current experiences whether children with cow’s milk or food allergy are at higher risk than a general population f
    Document: The COVID-19 pandemic is the most challenging global health crisis of our times. Vaccination against COVID-19 plays a key role to control the current pandemic situation. The risk of allergic reactions to new COVID-19 vaccines is low. However, there is a debate on the safety in allergic patients following post marketing findings by different agencies. Our aim is to understand from current experiences whether children with cow’s milk or food allergy are at higher risk than a general population for allergic reactions to COVID-19 vaccines. Current data indicate that patients with a history of allergy to cow’s milk or other foods, even if severe, should receive COVID-19 vaccine in a setting with availability of treatments for anaphylactic reactions and under medical supervision. Recipients should be discharged after a protracted observation period of 30 min if no reaction developed.

    Search related documents:
    Co phrase search for related documents
    • accurate screening and active ingredient: 1
    • accurate screening and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • active component and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • active ingredient and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • active substance and acute respiratory syndrome: 1, 2
    • acute respiratory syndrome and adenovirus vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute respiratory syndrome and adenovirus vector vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and adolescent adult: 1, 2, 3, 4, 5